AustralieFrV1, PubMed, Checkpoint, bibRecord, 002646

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.

Identifieur interne : 002646 ( PubMed/Checkpoint ); précédent : 002645; suivant : 002647

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.

Auteurs : Dean J. Kereiakes [États-Unis] ; Robert W. Yeh [États-Unis] ; Joseph M. Massaro [États-Unis] ; Priscilla Driscoll-Shempp [États-Unis] ; Donald E. Cutlip [États-Unis] ; P Gabriel Steg [Royaume-Uni] ; Anthony H. Gershlick [Royaume-Uni] ; Harald Darius [Allemagne] ; Ian T. Meredith [Australie] ; John Ormiston [Nouvelle-Zélande] ; Jean-François Tanguay [Canada] ; Stephan Windecker [Suisse] ; Kirk N. Garratt [États-Unis] ; David E. Kandzari [Géorgie (pays)] ; David P. Lee [États-Unis] ; Daniel I. Simon [États-Unis] ; Adrian Corneliu Iancu [Roumanie] ; Jaroslaw Trebacz [Pologne] ; Laura Mauri [États-Unis]

Source :

JACC. Cardiovascular interventions [ 1876-7605 ] ; 2015.

RBID : pubmed:26493248

Descripteurs français

English descriptors

KwdEn :
- Coronary Artery Disease (blood), Coronary Artery Disease (diagnosis), Coronary Artery Disease (mortality), Coronary Artery Disease (therapy), Coronary Thrombosis (diagnosis), Coronary Thrombosis (etiology), Coronary Thrombosis (mortality), Coronary Thrombosis (prevention & control), Double-Blind Method, Drug Therapy, Combination, Drug-Eluting Stents, Female, Humans, Male, Metals, Middle Aged, Myocardial Infarction (etiology), Myocardial Infarction (prevention & control), Percutaneous Coronary Intervention (adverse effects), Percutaneous Coronary Intervention (instrumentation), Percutaneous Coronary Intervention (mortality), Platelet Aggregation Inhibitors (adverse effects), Platelet Aggregation Inhibitors (therapeutic use), Propensity Score, Prospective Studies, Prosthesis Design, Risk Assessment, Risk Factors, Stents, Stroke (etiology), Stroke (prevention & control), Time Factors, Treatment Outcome.
MESH :
- chemical , adverse effects : Platelet Aggregation Inhibitors.
- chemical , therapeutic use : Platelet Aggregation Inhibitors.
- chemical : Metals.
- adverse effects : Percutaneous Coronary Intervention.
- blood : Coronary Artery Disease.
- diagnosis : Coronary Artery Disease, Coronary Thrombosis.
- etiology : Coronary Thrombosis, Myocardial Infarction, Stroke.
- instrumentation : Percutaneous Coronary Intervention.
- mortality : Coronary Artery Disease, Coronary Thrombosis, Percutaneous Coronary Intervention.
- prevention & control : Coronary Thrombosis, Myocardial Infarction, Stroke.
- therapy : Coronary Artery Disease.
- Double-Blind Method, Drug Therapy, Combination, Drug-Eluting Stents, Female, Humans, Male, Middle Aged, Propensity Score, Prospective Studies, Prosthesis Design, Risk Assessment, Risk Factors, Stents, Time Factors, Treatment Outcome.

Abstract

This study sought to compare rates of stent thrombosis and major adverse cardiac and cerebrovascular events (MACCE) (composite of death, myocardial infarction, or stroke) after coronary stenting with drug-eluting stents (DES) versus bare-metal stents (BMS) in patients who participated in the DAPT (Dual Antiplatelet Therapy) study, an international multicenter randomized trial comparing 30 versus 12 months of dual antiplatelet therapy in subjects undergoing coronary stenting with either DES or BMS.

DOI: 10.1016/j.jcin.2015.05.026
PubMed: 26493248

Affiliations:

Allemagne, Australie, Canada, Géorgie (pays), Nouvelle-Zélande, Pologne, Roumanie, Royaume-Uni, Suisse, États-Unis
Angleterre, Berlin, Californie, Canton de Berne, Delaware, Grand Londres, Massachusetts, Ohio, Québec
Berlin, Berne, Londres, Montréal

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002874
to stream PubMed, to step Curation: 002805

Links to Exploration step

pubmed:26493248

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.</title>
<author><name sortKey="Kereiakes, Dean J" sort="Kereiakes, Dean J" uniqKey="Kereiakes D" first="Dean J" last="Kereiakes">Dean J. Kereiakes</name>
<affiliation wicri:level="2"><nlm:affiliation>Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati, Ohio.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Yeh, Robert W" sort="Yeh, Robert W" uniqKey="Yeh R" first="Robert W" last="Yeh">Robert W. Yeh</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston, Massachusetts; Massachusetts General Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Massaro, Joseph M" sort="Massaro, Joseph M" uniqKey="Massaro J" first="Joseph M" last="Massaro">Joseph M. Massaro</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Boston University School of Public Health, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston, Massachusetts; Boston University School of Public Health, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Driscoll Shempp, Priscilla" sort="Driscoll Shempp, Priscilla" uniqKey="Driscoll Shempp P" first="Priscilla" last="Driscoll-Shempp">Priscilla Driscoll-Shempp</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Cutlip, Donald E" sort="Cutlip, Donald E" uniqKey="Cutlip D" first="Donald E" last="Cutlip">Donald E. Cutlip</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Department of Medicine, Cardiology Division, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Department of Medicine, Cardiology Division, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Steg, P Gabriel" sort="Steg, P Gabriel" uniqKey="Steg P" first="P Gabriel" last="Steg">P Gabriel Steg</name>
<affiliation wicri:level="3"><nlm:affiliation>Université Paris-Diderot, Paris, France, INSERM U-1148, Paris, France; Hôpital Bichat, Département Hospitalo-Universitaire FIRE, Assistance Publique-Hôpitaux de Paris, Paris, France; NHLI, Imperial College, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Université Paris-Diderot, Paris, France, INSERM U-1148, Paris, France; Hôpital Bichat, Département Hospitalo-Universitaire FIRE, Assistance Publique-Hôpitaux de Paris, Paris, France; NHLI, Imperial College, Royal Brompton Hospital, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gershlick, Anthony H" sort="Gershlick, Anthony H" uniqKey="Gershlick A" first="Anthony H" last="Gershlick">Anthony H. Gershlick</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Sciences, University of Leicester and National Institute of Health Research Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester, Leicester, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Cardiovascular Sciences, University of Leicester and National Institute of Health Research Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester, Leicester</wicri:regionArea>
<wicri:noRegion>Leicester</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Darius, Harald" sort="Darius, Harald" uniqKey="Darius H" first="Harald" last="Darius">Harald Darius</name>
<affiliation wicri:level="3"><nlm:affiliation>Vivantes Neukoelln Medical Center, Department of Cardiology, Angiology, Nephrology and Intensive Care Medicine, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Vivantes Neukoelln Medical Center, Department of Cardiology, Angiology, Nephrology and Intensive Care Medicine, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meredith, Ian T" sort="Meredith, Ian T" uniqKey="Meredith I" first="Ian T" last="Meredith">Ian T. Meredith</name>
<affiliation wicri:level="1"><nlm:affiliation>Monash Heart, Monash Health, Monash University, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Monash Heart, Monash Health, Monash University, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ormiston, John" sort="Ormiston, John" uniqKey="Ormiston J" first="John" last="Ormiston">John Ormiston</name>
<affiliation wicri:level="1"><nlm:affiliation>Mercy Hospital, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>Mercy Hospital, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tanguay, Jean Francois" sort="Tanguay, Jean Francois" uniqKey="Tanguay J" first="Jean-François" last="Tanguay">Jean-François Tanguay</name>
<affiliation wicri:level="3"><nlm:affiliation>Montreal Heart Institute, Department of Medicine/Division of Interventional Cardiology, Université de Montréal, Department of Medicine, Montreal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Montreal Heart Institute, Department of Medicine/Division of Interventional Cardiology, Université de Montréal, Department of Medicine, Montreal</wicri:regionArea>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Windecker, Stephan" sort="Windecker, Stephan" uniqKey="Windecker S" first="Stephan" last="Windecker">Stephan Windecker</name>
<affiliation wicri:level="3"><nlm:affiliation>Bern University Hospital, Department of Cardiology, Bern, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Bern University Hospital, Department of Cardiology, Bern</wicri:regionArea>
<placeName><settlement type="city">Berne</settlement>
<region type="région" nuts="3">Canton de Berne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garratt, Kirk N" sort="Garratt, Kirk N" uniqKey="Garratt K" first="Kirk N" last="Garratt">Kirk N. Garratt</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Heart and Vascular Health, Christiana Care, Wilmington, Delaware.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Delaware</region>
</placeName>
<wicri:cityArea>Center for Heart and Vascular Health, Christiana Care, Wilmington</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kandzari, David E" sort="Kandzari, David E" uniqKey="Kandzari D" first="David E" last="Kandzari">David E. Kandzari</name>
<affiliation wicri:level="1"><nlm:affiliation>Piedmont Heart Institute, Atlanta, Georgia.</nlm:affiliation>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Piedmont Heart Institute, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lee, David P" sort="Lee, David P" uniqKey="Lee D" first="David P" last="Lee">David P. Lee</name>
<affiliation wicri:level="2"><nlm:affiliation>Stanford University, Department of Medicine, Division of Cardiovascular Medicine, Stanford, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Stanford University, Department of Medicine, Division of Cardiovascular Medicine, Stanford</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Simon, Daniel I" sort="Simon, Daniel I" uniqKey="Simon D" first="Daniel I" last="Simon">Daniel I. Simon</name>
<affiliation wicri:level="2"><nlm:affiliation>University Hospitals Case Medical Center, Harrington Heart and Vascular Institute, Cleveland, Ohio.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Ohio</region>
</placeName>
<wicri:cityArea>University Hospitals Case Medical Center, Harrington Heart and Vascular Institute, Cleveland</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Iancu, Adrian Corneliu" sort="Iancu, Adrian Corneliu" uniqKey="Iancu A" first="Adrian Corneliu" last="Iancu">Adrian Corneliu Iancu</name>
<affiliation wicri:level="1"><nlm:affiliation>Heart Institute, University of Medicine Iuliu Hatieganu, Cluj Napoca, Romania.</nlm:affiliation>
<country xml:lang="fr">Roumanie</country>
<wicri:regionArea>Heart Institute, University of Medicine Iuliu Hatieganu, Cluj Napoca</wicri:regionArea>
<wicri:noRegion>Cluj Napoca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Trebacz, Jaroslaw" sort="Trebacz, Jaroslaw" uniqKey="Trebacz J" first="Jaroslaw" last="Trebacz">Jaroslaw Trebacz</name>
<affiliation wicri:level="1"><nlm:affiliation>Jan Pawel II Hospital Krakow, Krakow, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Jan Pawel II Hospital Krakow, Krakow</wicri:regionArea>
<wicri:noRegion>Krakow</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mauri, Laura" sort="Mauri, Laura" uniqKey="Mauri L" first="Laura" last="Mauri">Laura Mauri</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Brigham and Women's Hospital, Division of Cardiovascular Medicine, Boston, Massachusetts. Electronic address: lmauri1@partners.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston, Massachusetts; Brigham and Women's Hospital, Division of Cardiovascular Medicine, Boston</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26493248</idno>
<idno type="pmid">26493248</idno>
<idno type="doi">10.1016/j.jcin.2015.05.026</idno>
<idno type="wicri:Area/PubMed/Corpus">002874</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002874</idno>
<idno type="wicri:Area/PubMed/Curation">002805</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002805</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002805</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002805</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.</title>
<author><name sortKey="Kereiakes, Dean J" sort="Kereiakes, Dean J" uniqKey="Kereiakes D" first="Dean J" last="Kereiakes">Dean J. Kereiakes</name>
<affiliation wicri:level="2"><nlm:affiliation>Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati, Ohio.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Yeh, Robert W" sort="Yeh, Robert W" uniqKey="Yeh R" first="Robert W" last="Yeh">Robert W. Yeh</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston, Massachusetts; Massachusetts General Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Massaro, Joseph M" sort="Massaro, Joseph M" uniqKey="Massaro J" first="Joseph M" last="Massaro">Joseph M. Massaro</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Boston University School of Public Health, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston, Massachusetts; Boston University School of Public Health, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Driscoll Shempp, Priscilla" sort="Driscoll Shempp, Priscilla" uniqKey="Driscoll Shempp P" first="Priscilla" last="Driscoll-Shempp">Priscilla Driscoll-Shempp</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Cutlip, Donald E" sort="Cutlip, Donald E" uniqKey="Cutlip D" first="Donald E" last="Cutlip">Donald E. Cutlip</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Department of Medicine, Cardiology Division, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Department of Medicine, Cardiology Division, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Steg, P Gabriel" sort="Steg, P Gabriel" uniqKey="Steg P" first="P Gabriel" last="Steg">P Gabriel Steg</name>
<affiliation wicri:level="3"><nlm:affiliation>Université Paris-Diderot, Paris, France, INSERM U-1148, Paris, France; Hôpital Bichat, Département Hospitalo-Universitaire FIRE, Assistance Publique-Hôpitaux de Paris, Paris, France; NHLI, Imperial College, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Université Paris-Diderot, Paris, France, INSERM U-1148, Paris, France; Hôpital Bichat, Département Hospitalo-Universitaire FIRE, Assistance Publique-Hôpitaux de Paris, Paris, France; NHLI, Imperial College, Royal Brompton Hospital, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gershlick, Anthony H" sort="Gershlick, Anthony H" uniqKey="Gershlick A" first="Anthony H" last="Gershlick">Anthony H. Gershlick</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Sciences, University of Leicester and National Institute of Health Research Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester, Leicester, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Cardiovascular Sciences, University of Leicester and National Institute of Health Research Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester, Leicester</wicri:regionArea>
<wicri:noRegion>Leicester</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Darius, Harald" sort="Darius, Harald" uniqKey="Darius H" first="Harald" last="Darius">Harald Darius</name>
<affiliation wicri:level="3"><nlm:affiliation>Vivantes Neukoelln Medical Center, Department of Cardiology, Angiology, Nephrology and Intensive Care Medicine, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Vivantes Neukoelln Medical Center, Department of Cardiology, Angiology, Nephrology and Intensive Care Medicine, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meredith, Ian T" sort="Meredith, Ian T" uniqKey="Meredith I" first="Ian T" last="Meredith">Ian T. Meredith</name>
<affiliation wicri:level="1"><nlm:affiliation>Monash Heart, Monash Health, Monash University, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Monash Heart, Monash Health, Monash University, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ormiston, John" sort="Ormiston, John" uniqKey="Ormiston J" first="John" last="Ormiston">John Ormiston</name>
<affiliation wicri:level="1"><nlm:affiliation>Mercy Hospital, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>Mercy Hospital, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tanguay, Jean Francois" sort="Tanguay, Jean Francois" uniqKey="Tanguay J" first="Jean-François" last="Tanguay">Jean-François Tanguay</name>
<affiliation wicri:level="3"><nlm:affiliation>Montreal Heart Institute, Department of Medicine/Division of Interventional Cardiology, Université de Montréal, Department of Medicine, Montreal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Montreal Heart Institute, Department of Medicine/Division of Interventional Cardiology, Université de Montréal, Department of Medicine, Montreal</wicri:regionArea>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Windecker, Stephan" sort="Windecker, Stephan" uniqKey="Windecker S" first="Stephan" last="Windecker">Stephan Windecker</name>
<affiliation wicri:level="3"><nlm:affiliation>Bern University Hospital, Department of Cardiology, Bern, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Bern University Hospital, Department of Cardiology, Bern</wicri:regionArea>
<placeName><settlement type="city">Berne</settlement>
<region type="région" nuts="3">Canton de Berne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garratt, Kirk N" sort="Garratt, Kirk N" uniqKey="Garratt K" first="Kirk N" last="Garratt">Kirk N. Garratt</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Heart and Vascular Health, Christiana Care, Wilmington, Delaware.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Delaware</region>
</placeName>
<wicri:cityArea>Center for Heart and Vascular Health, Christiana Care, Wilmington</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kandzari, David E" sort="Kandzari, David E" uniqKey="Kandzari D" first="David E" last="Kandzari">David E. Kandzari</name>
<affiliation wicri:level="1"><nlm:affiliation>Piedmont Heart Institute, Atlanta, Georgia.</nlm:affiliation>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Piedmont Heart Institute, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lee, David P" sort="Lee, David P" uniqKey="Lee D" first="David P" last="Lee">David P. Lee</name>
<affiliation wicri:level="2"><nlm:affiliation>Stanford University, Department of Medicine, Division of Cardiovascular Medicine, Stanford, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Stanford University, Department of Medicine, Division of Cardiovascular Medicine, Stanford</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Simon, Daniel I" sort="Simon, Daniel I" uniqKey="Simon D" first="Daniel I" last="Simon">Daniel I. Simon</name>
<affiliation wicri:level="2"><nlm:affiliation>University Hospitals Case Medical Center, Harrington Heart and Vascular Institute, Cleveland, Ohio.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Ohio</region>
</placeName>
<wicri:cityArea>University Hospitals Case Medical Center, Harrington Heart and Vascular Institute, Cleveland</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Iancu, Adrian Corneliu" sort="Iancu, Adrian Corneliu" uniqKey="Iancu A" first="Adrian Corneliu" last="Iancu">Adrian Corneliu Iancu</name>
<affiliation wicri:level="1"><nlm:affiliation>Heart Institute, University of Medicine Iuliu Hatieganu, Cluj Napoca, Romania.</nlm:affiliation>
<country xml:lang="fr">Roumanie</country>
<wicri:regionArea>Heart Institute, University of Medicine Iuliu Hatieganu, Cluj Napoca</wicri:regionArea>
<wicri:noRegion>Cluj Napoca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Trebacz, Jaroslaw" sort="Trebacz, Jaroslaw" uniqKey="Trebacz J" first="Jaroslaw" last="Trebacz">Jaroslaw Trebacz</name>
<affiliation wicri:level="1"><nlm:affiliation>Jan Pawel II Hospital Krakow, Krakow, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Jan Pawel II Hospital Krakow, Krakow</wicri:regionArea>
<wicri:noRegion>Krakow</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mauri, Laura" sort="Mauri, Laura" uniqKey="Mauri L" first="Laura" last="Mauri">Laura Mauri</name>
<affiliation wicri:level="2"><nlm:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Brigham and Women's Hospital, Division of Cardiovascular Medicine, Boston, Massachusetts. Electronic address: lmauri1@partners.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston, Massachusetts; Brigham and Women's Hospital, Division of Cardiovascular Medicine, Boston</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">JACC. Cardiovascular interventions</title>
<idno type="eISSN">1876-7605</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Coronary Artery Disease (blood)</term>
<term>Coronary Artery Disease (diagnosis)</term>
<term>Coronary Artery Disease (mortality)</term>
<term>Coronary Artery Disease (therapy)</term>
<term>Coronary Thrombosis (diagnosis)</term>
<term>Coronary Thrombosis (etiology)</term>
<term>Coronary Thrombosis (mortality)</term>
<term>Coronary Thrombosis (prevention & control)</term>
<term>Double-Blind Method</term>
<term>Drug Therapy, Combination</term>
<term>Drug-Eluting Stents</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Metals</term>
<term>Middle Aged</term>
<term>Myocardial Infarction (etiology)</term>
<term>Myocardial Infarction (prevention & control)</term>
<term>Percutaneous Coronary Intervention (adverse effects)</term>
<term>Percutaneous Coronary Intervention (instrumentation)</term>
<term>Percutaneous Coronary Intervention (mortality)</term>
<term>Platelet Aggregation Inhibitors (adverse effects)</term>
<term>Platelet Aggregation Inhibitors (therapeutic use)</term>
<term>Propensity Score</term>
<term>Prospective Studies</term>
<term>Prosthesis Design</term>
<term>Risk Assessment</term>
<term>Risk Factors</term>
<term>Stents</term>
<term>Stroke (etiology)</term>
<term>Stroke (prevention & control)</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Accident vasculaire cérébral ()</term>
<term>Accident vasculaire cérébral (étiologie)</term>
<term>Adulte d'âge moyen</term>
<term>Antiagrégants plaquettaires (effets indésirables)</term>
<term>Antiagrégants plaquettaires (usage thérapeutique)</term>
<term>Association de médicaments</term>
<term>Conception de prothèse</term>
<term>Endoprothèses</term>
<term>Endoprothèses à élution de substances</term>
<term>Facteurs de risque</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infarctus du myocarde ()</term>
<term>Infarctus du myocarde (étiologie)</term>
<term>Intervention coronarienne percutanée (effets indésirables)</term>
<term>Intervention coronarienne percutanée (instrumentation)</term>
<term>Intervention coronarienne percutanée (mortalité)</term>
<term>Maladie des artères coronaires ()</term>
<term>Maladie des artères coronaires (diagnostic)</term>
<term>Maladie des artères coronaires (mortalité)</term>
<term>Maladie des artères coronaires (sang)</term>
<term>Mâle</term>
<term>Métaux</term>
<term>Méthode en double aveugle</term>
<term>Résultat thérapeutique</term>
<term>Score de propension</term>
<term>Thrombose coronarienne ()</term>
<term>Thrombose coronarienne (diagnostic)</term>
<term>Thrombose coronarienne (mortalité)</term>
<term>Thrombose coronarienne (étiologie)</term>
<term>Études prospectives</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Platelet Aggregation Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Platelet Aggregation Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Metals</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Percutaneous Coronary Intervention</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Coronary Artery Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronary Artery Disease</term>
<term>Coronary Thrombosis</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Maladie des artères coronaires</term>
<term>Thrombose coronarienne</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antiagrégants plaquettaires</term>
<term>Intervention coronarienne percutanée</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Coronary Thrombosis</term>
<term>Myocardial Infarction</term>
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Percutaneous Coronary Intervention</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronary Artery Disease</term>
<term>Coronary Thrombosis</term>
<term>Percutaneous Coronary Intervention</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Intervention coronarienne percutanée</term>
<term>Maladie des artères coronaires</term>
<term>Thrombose coronarienne</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronary Thrombosis</term>
<term>Myocardial Infarction</term>
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Intervention coronarienne percutanée</term>
<term>Maladie des artères coronaires</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronary Artery Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiagrégants plaquettaires</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Accident vasculaire cérébral</term>
<term>Infarctus du myocarde</term>
<term>Thrombose coronarienne</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Double-Blind Method</term>
<term>Drug Therapy, Combination</term>
<term>Drug-Eluting Stents</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Propensity Score</term>
<term>Prospective Studies</term>
<term>Prosthesis Design</term>
<term>Risk Assessment</term>
<term>Risk Factors</term>
<term>Stents</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Accident vasculaire cérébral</term>
<term>Adulte d'âge moyen</term>
<term>Association de médicaments</term>
<term>Conception de prothèse</term>
<term>Endoprothèses</term>
<term>Endoprothèses à élution de substances</term>
<term>Facteurs de risque</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infarctus du myocarde</term>
<term>Maladie des artères coronaires</term>
<term>Mâle</term>
<term>Métaux</term>
<term>Méthode en double aveugle</term>
<term>Résultat thérapeutique</term>
<term>Score de propension</term>
<term>Thrombose coronarienne</term>
<term>Études prospectives</term>
<term>Évaluation des risques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This study sought to compare rates of stent thrombosis and major adverse cardiac and cerebrovascular events (MACCE) (composite of death, myocardial infarction, or stroke) after coronary stenting with drug-eluting stents (DES) versus bare-metal stents (BMS) in patients who participated in the DAPT (Dual Antiplatelet Therapy) study, an international multicenter randomized trial comparing 30 versus 12 months of dual antiplatelet therapy in subjects undergoing coronary stenting with either DES or BMS.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26493248</PMID>
<DateCreated><Year>2015</Year>
<Month>10</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>08</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>10</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1876-7605</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>8</Volume>
<Issue>12</Issue>
<PubDate><Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>JACC. Cardiovascular interventions</Title>
<ISOAbbreviation>JACC Cardiovasc Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.</ArticleTitle>
<Pagination><MedlinePgn>1552-62</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcin.2015.05.026</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1936-8798(15)01160-7</ELocationID>
<Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study sought to compare rates of stent thrombosis and major adverse cardiac and cerebrovascular events (MACCE) (composite of death, myocardial infarction, or stroke) after coronary stenting with drug-eluting stents (DES) versus bare-metal stents (BMS) in patients who participated in the DAPT (Dual Antiplatelet Therapy) study, an international multicenter randomized trial comparing 30 versus 12 months of dual antiplatelet therapy in subjects undergoing coronary stenting with either DES or BMS.</AbstractText>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite antirestenotic efficacy of coronary DES compared with BMS, the relative risk of stent thrombosis and adverse cardiovascular events is unclear. Many clinicians perceive BMS to be associated with fewer adverse ischemic events and to require shorter-duration dual antiplatelet therapy than DES.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Prospective propensity-matched analysis of subjects enrolled into a randomized trial of dual antiplatelet therapy duration was performed. DES- and BMS-treated subjects were propensity-score matched in a many-to-one fashion. The study design was observational for all subjects 0 to 12 months following stenting. A subset of eligible subjects without major ischemic or bleeding events were randomized at 12 months to continued thienopyridine versus placebo; all subjects were followed through 33 months.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 10,026 propensity-matched subjects, DES-treated subjects (n = 8,308) had a lower rate of stent thrombosis through 33 months compared with BMS-treated subjects (n = 1,718, 1.7% vs. 2.6%; weighted risk difference -1.1%, p = 0.01) and a noninferior rate of MACCE (11.4% vs. 13.2%, respectively, weighted risk difference -1.8%, p = 0.053, noninferiority p < 0.001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">DES-treated subjects have long-term rates of stent thrombosis that are lower than BMS-treated subjects. (The Dual Antiplatelet Therapy Study [DAPT study]; NCT00977938).</AbstractText>
<CopyrightInformation>Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kereiakes</LastName>
<ForeName>Dean J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo><Affiliation>Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati, Ohio.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yeh</LastName>
<ForeName>Robert W</ForeName>
<Initials>RW</Initials>
<AffiliationInfo><Affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Massaro</LastName>
<ForeName>Joseph M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Boston University School of Public Health, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Driscoll-Shempp</LastName>
<ForeName>Priscilla</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Harvard Clinical Research Institute, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cutlip</LastName>
<ForeName>Donald E</ForeName>
<Initials>DE</Initials>
<AffiliationInfo><Affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Department of Medicine, Cardiology Division, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Steg</LastName>
<ForeName>P Gabriel</ForeName>
<Initials>PG</Initials>
<AffiliationInfo><Affiliation>Université Paris-Diderot, Paris, France, INSERM U-1148, Paris, France; Hôpital Bichat, Département Hospitalo-Universitaire FIRE, Assistance Publique-Hôpitaux de Paris, Paris, France; NHLI, Imperial College, Royal Brompton Hospital, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gershlick</LastName>
<ForeName>Anthony H</ForeName>
<Initials>AH</Initials>
<AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester and National Institute of Health Research Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester, Leicester, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Darius</LastName>
<ForeName>Harald</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Vivantes Neukoelln Medical Center, Department of Cardiology, Angiology, Nephrology and Intensive Care Medicine, Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Meredith</LastName>
<ForeName>Ian T</ForeName>
<Initials>IT</Initials>
<AffiliationInfo><Affiliation>Monash Heart, Monash Health, Monash University, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ormiston</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Mercy Hospital, Auckland, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tanguay</LastName>
<ForeName>Jean-François</ForeName>
<Initials>JF</Initials>
<AffiliationInfo><Affiliation>Montreal Heart Institute, Department of Medicine/Division of Interventional Cardiology, Université de Montréal, Department of Medicine, Montreal, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Windecker</LastName>
<ForeName>Stephan</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Bern University Hospital, Department of Cardiology, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Garratt</LastName>
<ForeName>Kirk N</ForeName>
<Initials>KN</Initials>
<AffiliationInfo><Affiliation>Center for Heart and Vascular Health, Christiana Care, Wilmington, Delaware.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kandzari</LastName>
<ForeName>David E</ForeName>
<Initials>DE</Initials>
<AffiliationInfo><Affiliation>Piedmont Heart Institute, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>David P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo><Affiliation>Stanford University, Department of Medicine, Division of Cardiovascular Medicine, Stanford, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Simon</LastName>
<ForeName>Daniel I</ForeName>
<Initials>DI</Initials>
<AffiliationInfo><Affiliation>University Hospitals Case Medical Center, Harrington Heart and Vascular Institute, Cleveland, Ohio.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Iancu</LastName>
<ForeName>Adrian Corneliu</ForeName>
<Initials>AC</Initials>
<AffiliationInfo><Affiliation>Heart Institute, University of Medicine Iuliu Hatieganu, Cluj Napoca, Romania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Trebacz</LastName>
<ForeName>Jaroslaw</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Jan Pawel II Hospital Krakow, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mauri</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Harvard Clinical Research Institute, Boston, Massachusetts; Brigham and Women's Hospital, Division of Cardiovascular Medicine, Boston, Massachusetts. Electronic address: lmauri1@partners.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>DAPT Study Investigators</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList><AccessionNumber>NCT00977938</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y"><Grant><GrantID>1R01FD003870-01</GrantID>
<Acronym>FD</Acronym>
<Agency>FDA HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>JACC Cardiovasc Interv</MedlineTA>
<NlmUniqueID>101467004</NlmUniqueID>
<ISSNLinking>1936-8798</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008670">Metals</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>JACC Cardiovasc Interv. 2015 Dec 21;8(14):1913</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003328" MajorTopicYN="N">Coronary Thrombosis</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054855" MajorTopicYN="Y">Drug-Eluting Stents</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008670" MajorTopicYN="Y">Metals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D062645" MajorTopicYN="N">Percutaneous Coronary Intervention</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bare-metal stents</Keyword>
<Keyword MajorTopicYN="N">drug-eluting stents</Keyword>
<Keyword MajorTopicYN="N">dual antiplatelet therapy</Keyword>
<Keyword MajorTopicYN="N">stent thrombosis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>03</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2015</Year>
<Month>05</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>05</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>10</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>10</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>8</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26493248</ArticleId>
<ArticleId IdType="pii">S1936-8798(15)01160-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.jcin.2015.05.026</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>Canada</li>
<li>Géorgie (pays)</li>
<li>Nouvelle-Zélande</li>
<li>Pologne</li>
<li>Roumanie</li>
<li>Royaume-Uni</li>
<li>Suisse</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Berlin</li>
<li>Californie</li>
<li>Canton de Berne</li>
<li>Delaware</li>
<li>Grand Londres</li>
<li>Massachusetts</li>
<li>Ohio</li>
<li>Québec</li>
</region>
<settlement><li>Berlin</li>
<li>Berne</li>
<li>Londres</li>
<li>Montréal</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="Ohio"><name sortKey="Kereiakes, Dean J" sort="Kereiakes, Dean J" uniqKey="Kereiakes D" first="Dean J" last="Kereiakes">Dean J. Kereiakes</name>
</region>
<name sortKey="Cutlip, Donald E" sort="Cutlip, Donald E" uniqKey="Cutlip D" first="Donald E" last="Cutlip">Donald E. Cutlip</name>
<name sortKey="Driscoll Shempp, Priscilla" sort="Driscoll Shempp, Priscilla" uniqKey="Driscoll Shempp P" first="Priscilla" last="Driscoll-Shempp">Priscilla Driscoll-Shempp</name>
<name sortKey="Garratt, Kirk N" sort="Garratt, Kirk N" uniqKey="Garratt K" first="Kirk N" last="Garratt">Kirk N. Garratt</name>
<name sortKey="Lee, David P" sort="Lee, David P" uniqKey="Lee D" first="David P" last="Lee">David P. Lee</name>
<name sortKey="Massaro, Joseph M" sort="Massaro, Joseph M" uniqKey="Massaro J" first="Joseph M" last="Massaro">Joseph M. Massaro</name>
<name sortKey="Mauri, Laura" sort="Mauri, Laura" uniqKey="Mauri L" first="Laura" last="Mauri">Laura Mauri</name>
<name sortKey="Simon, Daniel I" sort="Simon, Daniel I" uniqKey="Simon D" first="Daniel I" last="Simon">Daniel I. Simon</name>
<name sortKey="Yeh, Robert W" sort="Yeh, Robert W" uniqKey="Yeh R" first="Robert W" last="Yeh">Robert W. Yeh</name>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Steg, P Gabriel" sort="Steg, P Gabriel" uniqKey="Steg P" first="P Gabriel" last="Steg">P Gabriel Steg</name>
</region>
<name sortKey="Gershlick, Anthony H" sort="Gershlick, Anthony H" uniqKey="Gershlick A" first="Anthony H" last="Gershlick">Anthony H. Gershlick</name>
</country>
<country name="Allemagne"><region name="Berlin"><name sortKey="Darius, Harald" sort="Darius, Harald" uniqKey="Darius H" first="Harald" last="Darius">Harald Darius</name>
</region>
</country>
<country name="Australie"><noRegion><name sortKey="Meredith, Ian T" sort="Meredith, Ian T" uniqKey="Meredith I" first="Ian T" last="Meredith">Ian T. Meredith</name>
</noRegion>
</country>
<country name="Nouvelle-Zélande"><noRegion><name sortKey="Ormiston, John" sort="Ormiston, John" uniqKey="Ormiston J" first="John" last="Ormiston">John Ormiston</name>
</noRegion>
</country>
<country name="Canada"><region name="Québec"><name sortKey="Tanguay, Jean Francois" sort="Tanguay, Jean Francois" uniqKey="Tanguay J" first="Jean-François" last="Tanguay">Jean-François Tanguay</name>
</region>
</country>
<country name="Suisse"><region name="Canton de Berne"><name sortKey="Windecker, Stephan" sort="Windecker, Stephan" uniqKey="Windecker S" first="Stephan" last="Windecker">Stephan Windecker</name>
</region>
</country>
<country name="Géorgie (pays)"><noRegion><name sortKey="Kandzari, David E" sort="Kandzari, David E" uniqKey="Kandzari D" first="David E" last="Kandzari">David E. Kandzari</name>
</noRegion>
</country>
<country name="Roumanie"><noRegion><name sortKey="Iancu, Adrian Corneliu" sort="Iancu, Adrian Corneliu" uniqKey="Iancu A" first="Adrian Corneliu" last="Iancu">Adrian Corneliu Iancu</name>
</noRegion>
</country>
<country name="Pologne"><noRegion><name sortKey="Trebacz, Jaroslaw" sort="Trebacz, Jaroslaw" uniqKey="Trebacz J" first="Jaroslaw" last="Trebacz">Jaroslaw Trebacz</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002646 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002646 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:26493248
   |texte=   Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:26493248" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki